Photodynamic therapy for squamous cell carcinoma in situ on the extremities with ALA 10% gel and red light illumination.
Primary disease category: Cancer
Sponsor: Biofrontera
Projected enrollment dates: January 2018 to February 2019
Official study title: Photodynamic therapy for squamous cell carcinoma in situ on the extremities with ALA 10% gel and red light illumination.
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/pending